(Q34346158)

1 August 2017

Cefpiramide kinetics and plasma protein binding in cholestasis (English)

1 reference

1 August 2017

Demontes-Mainard F

1

1 reference

1 August 2017

Vinçon G

2

1 reference

1 August 2017

Labat L

3

1 reference

1 August 2017

Amouretti M

4

1 reference

1 August 2017

Necciari J

5

1 reference

1 August 2017

Kieffer G

6

1 reference

1 August 2017

Bannwarth B

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

3

1 reference

1 August 2017

295-297

1 reference

In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Pharmacokinetic properties of the cephalosporins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

High hepatic excretion in humans of cefpiramide, a new cephalosporin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Pharmacokinetics of ceftriaxone in liver-transplant recipients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364762

Pharmacokinetics of cefpiramide (SM-1652) in humans

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04278.X

Noncompartmental Determination of the Steady‐State Volume of Distribution

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04278.X

Micromethod for the determination of cefpiramide in human plasma and urine by high-performance liquid chromatography using automated column switching

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of cefpiramide in rats with obstructive jaundice

1 reference

12 December 2020

Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis

1 reference

12 December 2020

Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis

1 reference

12 December 2020

10.1111/J.1365-2125.1994.TB04278.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference